Hughes & Company Secures $260 Million to Drive Healthcare Innovations and Efficiency

Hughes & Company Secures $260 Million for Healthcare Innovations

Hughes & Company, a private equity firm dedicated to healthcare software and technology-enabled services, successfully closes its second private equity fund, Hughes Growth Equity Fund II, L.P., at a hard cap of $260 million. The firm exceeds its initial target of $200 million, reflecting robust investor confidence in its strategy and mission. Managing Partner and Founder, Travis Hughes, expresses gratitude to both existing and new investors, emphasizing the firm’s commitment to transforming the healthcare system. By investing in companies that prioritize cost reduction and enhanced efficiency, Hughes & Company aims to foster long-term improvements in patient care.

The firm’s investment team, composed of seasoned industry experts, focuses not only on financial support but also on enhancing the capabilities and culture of the companies it invests in. This holistic approach is designed to build lasting value within the healthcare landscape. Since its inception in 2010, Hughes & Company has demonstrated a strong track record, notably through its first fund, Hughes Growth Equity Fund I, L.P., which closed in 2021 at $116 million and supported multiple growth-stage companies. The firm’s strategic focus on healthcare innovation positions it to play a pivotal role in shaping future developments within the sector.

Hughes & Company’s commitment to driving growth and innovation is further illustrated by its recent investment initiatives. The firm has already made its first investment from Fund II through a merger between Curvo and BroadJump, which together create a comprehensive spend management and analytics platform specifically designed for hospitals and health systems. This strategic merger is aimed at delivering advanced tools that not only reduce costs but also improve operational outcomes, consolidating Hughes & Company’s role as a catalyst for change in the healthcare industry.

In addition to its successful funding efforts, Hughes & Company has a proven history of impactful exits, such as its recent sale of Azara Healthcare, a population health management software provider, to Insight Partners in late 2024. This exit underscores the firm’s ability to identify and cultivate high-potential companies, ultimately delivering value to its investors and improving healthcare delivery systems. The firm remains steadfast in its mission to enhance patient care and operational efficiency through strategic investments in the healthcare sector.